Merck Nixes study on prostate cancer where Keytruda therapy disappoints

Published Date: 02 Mar 2023

Merck & Co has halted late-stage trials of the combination with cancer drug Keytruda because preliminary data showed it was unlikely to achieve its primary goal.

Read Full News

Latest News

Are We Training Doctors for the Systems They'll Inherit?

Medical exchanges with five health systems showed one medical student that the answer is no.

Hospitalists Face a Growing Risk for Decision-Making Fatigue

A combination of large patient load and ‘a million decisions a day’ can lead to poorer outcomes.

How Pharmacists Can Strengthen Drug Safety Monitoring

Pharmacists play a key role in spotting suspected adverse reactions early, even when the link to a medicine is uncertain.

Congenital Ichthyosis Tied to Risk for Allergic Disorders

Patients with congenital ichthyosis may have significantly higher rates of allergic rhinitis, food allergy, and allergic asthma than those in the general population, a survey finds.

Does CKD Severity Predict Adverse ICU Outcomes?

Among patients in the ICU, the presence and severity of chronic kidney disease are tied to a higher risk for mortality; among those who receive maintenance dialysis, the risk is comparatively lower.

Gram-Negative Bacteria Lead Pediatric Cancer BSIs

Gram-negative bacteria account for nearly 70% of bloodstream infections in pediatric oncology patients, with nonsusceptibility rates of some organisms to antibiotics increasing.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Latest News

Medical exchanges with five health systems showed one medical student that the answer is no.

A combination of large patient load and ‘a million decisions a day’ can lead to poorer outcomes.

Pharmacists play a key role in spotting suspected adverse reactions early, even when the link to a medicine is uncertain.

Patients with congenital ichthyosis may have significantly higher rates of allergic rhinitis, food allergy, and allergic asthma than those in the general population, a survey finds.

Among patients in the ICU, the presence and severity of chronic kidney disease are tied to a higher risk for mortality; among those who receive maintenance dialysis, the risk is comparatively lower.

Gram-negative bacteria account for nearly 70% of bloodstream infections in pediatric oncology patients, with nonsusceptibility rates of some organisms to antibiotics increasing.

News All Time

New Evidence Links Atopic Dermatitis to Herpes Zoster

A study of more than 13 million people in the UK finds an association between atopic dermatitis and herpes zoster, including after adjusting for comorbidities, treatments, and other factors.

Antiphospholipid Antibodies Linked to Pregnancy Risks in SLE

Certain antiphospholipid antibody profiles are associated with increased odds of adverse pregnancy outcomes in women with systemic lupus erythematosus.

Metabolic, Autoimmune Links Seen in Sclerosing Mesenteritis

Patients with symptomatic sclerosing mesenteritis often present with abdominal pain and have concurrent autoimmune, malignant, or metabolic disorders.

How Immigration Raids Emptied a Local Pediatric Clinic

Fear of immigration operations keeps vulnerable families away from the doctor, driving a sharp rise in missed appointments and leaving critical childhood care on hold.

Air Pollution Linked to Rise in RA Flares, Disease Activity

New research adds greater strength to previous findings that associate exposure to fine particulate matter with higher disease activity and flare risk in patients with rheumatoid arthritis.

This Is What mRNA Vaccines May Actually Do in the Body

Muscle cells, not just dendritic cells, help mRNA vaccines work, with big implications for vaccine and therapy design.

Arbovirus Surge Prompts CDC Warning for Anti-CD20s

Patients taking immune-suppressing therapies are at higher risk for neuroinvasive illness from ticks and mosquitoes.

Psychiatric Disorders Emerge Early in MOGAD

Psychiatric comorbidities are common in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, particularly depression, anxiety, and ADHD, a study shows.

Rabies in an 11-Year-Old Boy After Bat Contact

Early facial numbness and sore gums masked a deadly diagnosis in a boy who had direct bat contact but no obvious wound.

Wheat Sensitivity: Is Gluten the Only Trigger?

Symptoms associated with wheat sensitivity may involve more than gluten, making careful testing important before dietary restriction and limiting reliance on self-diagnosis.

Vitiligo Severity Assessments Vary Among HCPs

US and Europe healthcare providers describe inconsistent approaches to nonsegmental vitiligo severity, with quality of life, repigmentation, and progression influencing treatment decisions.

Schools Need Proactive Asthma Care Plans

Fewer than a third of children’s schools are equipped to manage emergent asthma exacerbations, a study shows.

Race and Language May Shape Kids’ Asthma ED Care

Race, gender, language, and chronic illness may influence hospital outcomes after an ED visit for asthma, but the standard social drivers of health indices miss geographic patterns behind it.

Deep Dive: PCSK9 Inhibitors: Five Agents, New Rules

An oral macrocyclic peptide has joined two monoclonal antibodies, an siRNA, and a monthly fusion protein. Ann Marie Navar, MD, PhD, on why that changes prescribing.

Abrocitinib Alters Skin Microbiome in Atopic Dermatitis

Treatment with abrocitinib is associated with reduced Staphylococcus aureus abundance and increased skin microbial diversity in patients with moderate-to-severe atopic dermatitis.

Experts: States Not Likely to Change Vaccine Policy After EO

An Executive Order implicitly threatened states that do not align with its recommendations, but experts say the administration would be on shaky legal ground.

Recommended News For You

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

From Pathology to Precision: The Story of Leukemia Therapy

FDA Approves New ROS1 Inhibitor for NSCLC

Can Exercise Extend Survival After Breast Cancer?

A video animation guide to assist young people who are fatigued from cancer.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Recommended Articles For You

Precision Medicine in Modern Cancer Therapy 

Decoding Hamartomas: Understanding Their Causes and Symptoms 

Modern Developments in Oncology for Specialists 

AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Virtual Reality Travel Reduces Cancer Pain.

1.

Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective

2.

Iron Homeostasis Throughout the Female Lifespan

3.

The Benefits and Side Effects of Vidaza Syndrome 

4.

Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models

5.

Exercise Rehabilitation in Hematologic Disease Survivorship

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

3.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot